Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
6
Translate
Report
5028 Views
Comment
Sign in to post a comment
luckme
:
Transformed from a medical device company to a contract development and manufacturing organization in the field of cellular gene therapy.
The facility is expected to be available to customers in the second or third quarter of this year. ThermoGenesis expects the facility to generate around $100,000 to $160,000 in annual revenue if fully occupied.
luckme
:
March 16, 2023 /PRNewswire/ — ThermoGenesis Holdings, Inc. (NASDAQ: THMO), the market leader in automated cell processing tools and services in the field of cell and gene therapy, announced today that it has reached a final agreement on the purchase and sale of its 1,071,429 common shares (or common stock equivalents) and warrants. The purchase price of the common stock is $2.80 per common share (or common stock equivalent). The relevant warrants in private placement are priced at -NASDAQ The market under the gram rule. The exercise price of the warrants is $2.65 per share, which will be exercised immediately after issuance and expire five and a half years after issuance.
RunRun
OP
luckme
:
Thank you for your response. Does this mean that every unit now only costs $2.65 or $2.80? Mine is at $4 plus per share. So, I have already made a loss?
luckme
RunRun
OP
:
You are at the price of 4 yuan. Of course, you lost money. I suggest you make up for the small position, lower the cost, and wait for it to rebound in frequency. Anyway, I opened a small position today. I bought 500 shares at 2.56. If it falls, I'll add 500. This is just my suggestion. You need to decide whether to replenish the position based on your own investment
RunRun
OP
luckme
:
Oh dear... and I was still thinking maybe it will rebound. I bought the wrong stock. ok, thank you for your advice. Much appreciated!
luckme : Transformed from a medical device company to a contract development and manufacturing organization in the field of cellular gene therapy.
The facility is expected to be available to customers in the second or third quarter of this year. ThermoGenesis expects the facility to generate around $100,000 to $160,000 in annual revenue if fully occupied.
luckme : March 16, 2023 /PRNewswire/ — ThermoGenesis Holdings, Inc. (NASDAQ: THMO), the market leader in automated cell processing tools and services in the field of cell and gene therapy, announced today that it has reached a final agreement on the purchase and sale of its 1,071,429 common shares (or common stock equivalents) and warrants. The purchase price of the common stock is $2.80 per common share (or common stock equivalent). The relevant warrants in private placement are priced at -NASDAQ The market under the gram rule. The exercise price of the warrants is $2.65 per share, which will be exercised immediately after issuance and expire five and a half years after issuance.
luckme : The current price is close to its private placement price, this is what happened with this company
RunRun OP luckme : Thank you for your response. Does this mean that every unit now only costs $2.65 or $2.80? Mine is at $4 plus per share. So, I have already made a loss?
luckme RunRun OP : You are at the price of 4 yuan. Of course, you lost money. I suggest you make up for the small position, lower the cost, and wait for it to rebound in frequency. Anyway, I opened a small position today. I bought 500 shares at 2.56. If it falls, I'll add 500. This is just my suggestion. You need to decide whether to replenish the position based on your own investment
RunRun OP luckme : Oh dear... and I was still thinking maybe it will rebound. I bought the wrong stock. ok, thank you for your advice. Much appreciated!